Education

  • MD, New York Medical College, Valhalla, NY, 2004
  • General Surgery Residency, University of Wisconsin Hospital and Clinics, Madison, WI, 2011
  • Research Fellowship, Memorial Sloan Kettering Cancer Center, New York, NY, 2008
  • Clinical Fellowship, Memorial Sloan Kettering Cancer Center, New York, NY, 2013
  • MAS, University of California San Diego, San Diego, CA, 2019

Clinical Specialties

Dr. Kelly’s primary clinical practice includes the treatment of upper gastrointestinal malignancies, including gastric, pancreatic, and hepatobiliary cancers, as well as peritoneal surface malignancy, melanoma, and sarcoma. She is particularly interested in developing minimally invasive techniques for cancer surgery. Dr. Kelly’s primary clinical and research interest is gastric cancer. She is among the highest-volume gastric cancer surgeons in the country with over 10 year of experience, and has pioneered minimally-invasive surgical techniques for gastrectomy with comprehensive lymph node removal. Dr. Kelly also performs some operations with an open technique when necessary, and can perform additional procedures to treat liver cysts, chronic pancreatitis, and gallbladder disease. Dr. Kelly is board-certified in Complex General Surgical Oncology and General Surgery.

Research Interests

Dr. Kelly is a clinical and translational researcher. She is a Nationally-recognized expert in gastric cancer treatment and much of her research is aimed to improve the quality of gastric cancer surgery as it is performed across the U.S.  She is also involved in the development and conduct of clinical trials. Dr. Kelly is an active member of the Alliance for Clinical Trials in Oncology, the Eastern Cooperative Oncology Group (ECOG), the American College of Surgeons, the Society of Surgical Oncology, and the American Society of Clinical Oncology.

Recent Publications

  • Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey.
    Sherwinter DA, Boni L, Bouvet M, Ferri L, Hyung WJ, Ishizawa T, Kaleya RN, Kelly K, Kokudo N, Lanzarini E, Luyer MDP, Mitsumori N, Mueller C, Park DJ, Ribero D, Rosati R, Ruurda JP, Sosef M, Schneider-Koraith S, Spinoglio G, Strong V, Takahashi N, Takeuchi H, Wijnhoven BPL, Yang HK, Dip F, Lo Menzo E, White KP, Rosenthal RJ
    Surgery 2022 Dec; 172(6S): S29-S37
    [PubMed ID: 36427927]

  • ASO Visual Abstract: Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
    Khan S, Doan NH, Hosseini M, Kelly K, Veerapong J, Lowy AM, Baumgartner J
    Ann Surg Oncol 2022 Nov 11;
    [PubMed ID: 36369408]

  • ASO Author Reflections: A Change Package as a Dissemination Tool for Gastric Cancer Care.
    Kelly K
    Ann Surg Oncol 2022 Oct 30;
    [PubMed ID: 36310310]

  • Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
    Khan S, Doan NH, Hosseini M, Kelly K, Veerapong J, Lowy AM, Baumgartner J
    Ann Surg Oncol 2022 Oct 28;
    [PubMed ID: 36305990]

  • Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer: A Pilot Study.
    Mehta SN, Shenvi EC, Blair SL, Caudle A, Lowenstein LM, Kelly KJ
    Ann Surg Oncol 2022 Oct 12; 1-10
    [PubMed ID: 36222932]

All Publications on PubMed